보형물연관 역형성대세포림프종 BIA-ALCL

This article aims to provide recommendations on breast implant-associated anaplastic large cell lymphoma (BIA-ALCL), caused by textured breast implants. These recommendations are based on both updated data from the literature and the experi…

Breast implant-associated diffuse large B-cell lymphoma (BIA-DLBCL) is an extremely rare entity, often misdiagnosed as breast implant-associated anaplastic large cell lymphoma (BIA-ALCL). Unlike BIA-ALCL, which is a T-cell neoplasm, BIA-DLB…

[BACKGROUND] Augmentation mastopexy is complex due to the biomechanical conflict between lifting ptotic tissue and introducing volume with implants. In medium-to-large breasts or in patients with poor tissue quality, the imbalance between n…

Increased awareness of textured breast implants' association with breast implant-associated anaplastic large cell lymphoma has led to rising rates exchange from textured anatomic implants to smooth round implants, which can alter breast est…

: Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) is a T-cell lymphoma that has shown an interest in the medical community in recent years. Given its emerging clinical relevance, accurate imaging plays a crucial role in …

: Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) is a mature T-cell lymphoma linked to textured breast implants. A leading hypothesis suggests that chronic inflammation, combined with immunological and genetic factors, …

Smooth implants, favored for their lower risk of rupture and BIA-ALCL, encounter stability challenges in preventing implant displacement and bottoming out. Therefore, a stronger support of the lower pole is necessary to immobilize the impla…

The optimal treatment of patients with breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) that underwent incomplete resection, have advanced stage disease or relapse after resection remains unknown. We describe the treatmen…

[BACKGROUND] Despite nearly three decades of investigation since its initial report, breast implant associated-anaplastic large cell lymphoma (BIA-ALCL) remains an elusive and evolving clinical entity. [OBJECTIVES] This manuscript presents…

Plastic surgery research faces a fundamental challenge in the era of artificial intelligence; individual departments rarely possess sufficient case volumes to train robust machine learning models, particularly for specialized procedures or …

Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) is a type of T-cell lymphoma arising near textured breast implants. In a Dutch population, a higher prevalence of BRCA1/2 was found in BIA-ALCL. We analyzed the risk of BIA…

Stakeholders in the breast implant industry in Korea have recently experienced a crisis from breast implant-associated anaplastic large cell lymphoma and the first Korean case of a medical device fraud. We compared the short-term safety bet…

[BACKGROUND] Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) has become a significant concern in plastic surgery, particularly following the 2019 recall of Allergan macro-textured implants. While research has addressed i…

The pathophysiology of breast implant-related adverse outcomes, such as capsular contracture and breast implant-associated anaplastic large cell lymphoma, remains poorly understood. Herein, we explore the direct and indirect effects of smoo…

Breast augmentation may be performed using round or anatomical shaped implants, and since their introduction in 1993, the indications and outcomes of anatomical implants have been under scrutiny. In fact, due to their asymmetric shape, thes…

[INTRODUCTION] Breast augmentation remains one of the most common cosmetic surgical procedures globally yet implant surface preference (textured versus smooth) remains a key area of debate. Whilst textured implants have traditionally been f…

[BACKGROUND] Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) has affected more than 1700 women. Treatment morbidity is reduced and survival improved by early detection and removal of implant and capsule. [OBJECTIVE] To …

Breast lymphomas, though rare, present a unique spectrum of clinical and pathological characteristics. This multicenter retrospective study evaluates 92 cases from four international institutions over a ten-year period to provide a comprehe…

The increasing use of breast implants in cosmetic and reconstructive surgery has brought attention to rare malignancies linked to the capsule that forms around them, such as breast implant-associated anaplastic large cell lymphoma, angiosar…